Abstract:1270 Objectives: It is proposed to establish a different level of drug-resistant pancreatic cancer cell line, in order to evaluate whether 18F-FDG PET/CT imaging can evaluate the chemoresistance of pancreatic cancer to gemcitabine (GEM) in the early stage. In vitro and in vivo , the difference of 18F-FDG uptake value among the drug-resistant cell lines is compared , and the effect of the 18F-FDG PET/CT imaging on the glucose metabolism is discussed . Methods: Using PANC-1 as parent pancreatic cancer cell, cell lines were established by gradient concentration doubling method with low dose to high dose GEM (1 μg/ml to 10 μg/ml), which was defined as PANC-1L and PANC-1H. CCK8 tests were examined to determine the degree of drug resistance. The uptake and outflow of 18F-FDG: cells were inoculated with 1 μCi/one hundred thousand per hole. After 60 minutes, the intra- and extra-cellular radioactivity count value per minute (CPM) was measured by GC-911γ counter, and the 18F-FDG uptake ratio was calculated; Then the culture medium without 18F-FDG was replaced, and CPM of intracellular was measured at 10, 30, 60 minutes. The 18F-FDG efflux percentage was calculated. Western Blot was used to detect The expression level of protein HK1, HK2, GLUT1, GLUT2. Sigma glucose detection kit and lactate detection kit were used to determine the glucose consumption and lactic acid production of different cell lines. Abcam HK activity assay kit were used to explore HK activity. Three cell lines were inoculated with BALB/c nude mice and 18F-FDG PET/CT imaging was performed. Draw ROI to get SUVmax value. Results: CCK8 tests: IC50s of PANC-1, PANC-1L and PANC-1Hwere 98.41ng/ml, 416.8ng/ml and 831.6ng/ml. The uptake and outflow of 18F-FDG: With the increase of drug resistance, the uptake of 18F-FDG decreased (p l 0.01), and the efflux increased (p l 0.05). Western Blot: With the increase of drug resistance, the expression of HK2, GLUT2 and LDHA increased and the expression of HK1 decreased. There was no significant difference in the expression of GLUT1. Glycometabolism related assay kit: With the increase of drug resistance, glucose consumption and lactic acid production increased (p l 0.05 vs p l 0.01); However, there was no significant difference in HK activity between two groups (p g 0.05). The vivo imaging showed that the SUVmax of parent tumor was 1.98 ±1.12, the SUVmax of low-grade drug-resistant tumor was 1.27 ±0.21, the SUVmax of high-grade drug-resistant tumor was 0.94 ±0.07; The SUVmax of parent tumor was higher than that of drug resistant tumor (p l 0.05), but the difference of SUVmax between PANC-1L and PANC-1H was not significant (p g 0.05). Conclusions: Drug-resistant pancreatic cancer cells had lower 18F-FDG uptake ratio, which may be due to the decrease of HK activity and the increase of GLUT2 expression that resulted in the decrease of 18F-FDG retention index and the increase of 18F-FDG efflux. But the mechanism of the increase of glucose consumption and lactic acid production in drug-resistant pancreatic carcinoma may be caused by upregulating the expression of LDHA, which enhanced glycolysis.

Hypoxia-induced modulation of glucose transporter expression impacts 18 F-fluorodeoxyglucose PET-CT imaging in hepatocellular carcinoma

Relationships Between Expression of Glucose Transporter Protein-1 and Hypoxia Inducible Factor-1Α, Prognosis and 18F-FDG Uptake in Laryngeal and Hypopharyngeal Carcinomas

Clinical Significance of FDG Single-Photon Emission Computed Tomography: Computed Tomography in the Diagnosis of Head and Neck Cancers and Study of Its Mechanism.

Expression and Significance of Hypoxia-Inducible Factor-1Α and Glucose Transporter-1 in Laryngeal Carcinoma.

Expression of glucose transporter-1 and -3 in the head and neck carcinoma--the correlation of the expression with the biological behaviors.

Expression of Glucose Transporter in Non-Small Cell Lung Carcinoma and Its Clinical Significance

Fluorodeoxyglucose Uptake in Laryngeal Carcinoma is Associated with the Expression of Glucose Transporter-1 and Hypoxia-Inducible-factor-1α and the Phosphoinositide 3-Kinase/protein Kinase B Pathway.

Cancer-associated Fibroblasts Enhance Tumor 18F-FDG Uptake and Contribute to the Intratumor Heterogeneity of PET-CT.

Expression of Glut-1 in primary and recurrent head and neck squamous cell carcinomas, and compared with 2-[18F]fluoro-2-deoxy-D-glucose accumulation in positron emission tomography.

In vivo evaluation of the effects of simultaneous inhibition of GLUT-1 and HIF-1α by antisense oligodeoxynucleotides on the radiosensitivity of laryngeal carcinoma using micro 18F-FDG PET/CT

Correlation of Glucose Transporter 1(GLUT1) Increased Expression with FDG Uptaking in Human Lung Cancer

Correlation of metabolism/hypoxia markers and fluorodeoxyglucose uptake in oral squamous cell carcinomas

Role of GLUT-1 in the Upregulation of PD-L1 Expression after Radiotherapy and Association of PD-L1 with Favourable Overall Survival in Hypopharyngeal Cancer

GLUT1 Expression and FDG Acumulation in Head and Neck Squamous Cell Carcinoma and Their Correlations

Likely Common Role of Hypoxia in Driving 18F-FDG Uptake in Cancer, Myocardial Ischemia, Inflammation and Infection.

Data from Transcriptomics Associates Molecular Features with <sup>18</sup>F-Fluorocholine PET/CT Imaging Phenotype and Its Potential Relationship to Survival in Hepatocellular Carcinoma

Transcriptomics associates molecular features with 18F-fluorocholine PET/CT imaging phenotype and its potential relationship to survival in hepatocellular carcinoma.

A Preliminary Study of the Effect of the Degree of Drug Resistance of Pancreatic Cancer on F-18-FDG Uptake Value and Its Mechanism

Reciprocal change in Glucose metabolism of Cancer and Immune Cells mediated by different Glucose Transporters predicts Immunotherapy response

Effect of Blood Glucose Level on 18 F-FDG PET/CT Imaging

Fluorine-18-fluorodeoxyglucose-PET/computed Tomography Has a Role in Predicting the Outcome of Hepatocellular Carcinoma